Abstract
To report the long-term safety and efficacy data of a third generation drug eluting stent (DES) with biodegradable polymer in the complex patient population of diabetes mellitus after a follow-up period of 5 years. After percutaneous coronary intervention patients with diabetes mellitus are under higher risk of death, restenosis and stent thrombosis (ST) compared to non-diabetic patients. In 126 centers worldwide 3067 patients were enrolled in the NOBORI 2 registry, 888 patients suffered from diabetes mellitus (DM), 213 of them (14%) being insulin dependent (IDDM). Five years follow-up has been completed in this study. At 5 years, 89.3% of the patients were available for follow-up. The reported target lesion failure (TLF) rates at 5 years were 12.39% in DM group and 7.34% in non-DM group; (p < 0.0001). In the DM group, the TLF rate in patients with IDDM was significantly higher than in the non-IDDM subgroup (17.84 vs. 10.67%; p < 0.01). The rate of ST at 5 years was not different among diabetic versus non-diabetic patients or IDDM versus NIDDM. Only 10 (<0.4%) very late stent thrombotic events beyond 12 months occurred. The Nobori DES performed well in patients with DM. As expected patients with DM, particularly those with IDDM, had worse outcomes. However, the very low rate of very late stent thrombosis in IDDM patients might have significant clinical value in the treatment of these patients. Clinical trial registration ISRCTN81649913; http://www.controlled-trials.com/isrctn/search.html?srch=81649913&sort=3&dir=desc&max=10
Highlights
Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow‐up
Marcus Wiemer1*, Sinisa Stojkovic2, Alexander Samol1, Zisis Dimitriadis3, Juan M
The online version of the original article can be found under doi:10.1186/s12933-017-0500-3
Summary
Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow‐up Marcus Wiemer1*, Sinisa Stojkovic2, Alexander Samol1, Zisis Dimitriadis3, Juan M. Ruiz‐Nodar4, Ralf Birkemeyer5, Jacques Monsegu6, Gérard Finet7, David Hildick‐Smith8, Damras Tresukosol9, Enrique Garcia Novo10, Jacques J. Koolen11, Emanuele Barbato12,14, Gian Battista Danzi13 and on behalf of NOBORI 2 investigators The family name of Sinisa Stojkovic was incorrectly spelled ‘Stoikovic’.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.